Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma.
about
Hepatitis B virus X protein upregulates HSP90alpha expression via activation of c-Myc in human hepatocarcinoma cell line, HepG2Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progressionThe Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomasHepatitis Bx antigen stimulates expression of a novel cellular gene, URG4, that promotes hepatocellular growth and survivalAEG-1/MTDH/LYRIC in liver cancerUnderstanding the role of PIN1 in hepatocellular carcinomaHepatitis B spliced protein (HBSP) promotes the carcinogenic effects of benzo [alpha] pyrene by interacting with microsomal epoxide hydrolase and enhancing its hydrolysis activityEnchanced levels of apolipoprotein M during HBV infection feedback suppresses HBV replicationVirtual screening of natural inhibitors to the predicted HBx protein structure of Hepatitis B Virus using molecular docking for identification of potential lead molecules for liver cancerSeparate origins of hepatitis B virus surface antigen-negative foci and hepatocellular carcinomas in transgenic HBsAg (alb/psx) mice.Transformation of human liver L-O2 cells mediated by stable HBx transfection.C-terminal truncated hepatitis B virus X protein regulates tumorigenicity, self-renewal and drug resistance via STAT3/Nanog signaling pathway.Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex.Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic miceCarboxyl-terminal truncated HBx regulates a distinct microRNA transcription program in hepatocellular carcinoma developmentMobile elements and viral integrations prompt considerations for bacterial DNA integration as a novel carcinogenRole of miR-148a in hepatitis B associated hepatocellular carcinoma.From chronic liver disorders to hepatocellular carcinoma: Molecular and genetic pathways.Hepatitis B virus HBx protein interactions with the ubiquitin proteasome system.Upregulated expression of a unique gene by hepatitis B x antigen promotes hepatocellular growth and tumorigenesis.Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma.Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells?TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma.Hepatitis B Virus-Related Hepatocellular Carcinoma: Pathogenic Mechanisms and Novel Therapeutic Interventions.p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumour ablation.Hepatitis B virus X protein targets Bcl-2 proteins to increase intracellular calcium, required for virus replication and cell death induction.Hepatitis B virus X protein targets the Bcl-2 protein CED-9 to induce intracellular Ca2+ increase and cell death in Caenorhabditis elegans.Construction of eukaryotic expression vector of HBV x gene.Preliminary study on the production of transgenic mice harboring hepatitis B virus X gene.Expression of hepatitis B virus X protein in transgenic mice.Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analysesViral genotypes and associated risk factors of hepatocellular carcinoma in India.HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stressHepatitis viruses and non-Hodgkin's lymphoma: A reviewA case-control study of the relationship between hepatitis B virus DNA level and risk of hepatocellular carcinoma in Qidong, China.HBx Gene Mutations in Hepatitis B Virus and Hepatocellular Carcinoma.Increased expression of ErbB-2 in liver is associated with hepatitis B x antigen and shorter survival in patients with liver cancer.Putative roles of hepatitis B x antigen in the pathogenesis of chronic liver disease.A comprehensive molecular interaction map for Hepatitis B virus and drug designing of a novel inhibitor for Hepatitis B X protein.
P2860
Q21245106-0D779E5F-9109-4517-A73A-9815BC951E43Q24320028-E7DFCF8D-7C1B-4849-82A5-A0864CDE6F9EQ24647547-38081675-6FE5-4522-907C-D2F92D8E2B46Q24681487-57769499-5FDD-486A-87A8-1993EDB496EBQ24682883-35F84B7D-966F-4938-B254-B10C84277061Q26822570-B1D799C4-38C1-42A5-B8C0-77702003AD66Q28073477-E971E22C-BF40-4C33-8AE1-C51205270F8DQ28384850-4DA87334-5D5A-449E-8889-9D6CA0D9FFB6Q28740406-CE857736-7B0E-414C-87DF-1E94E06CD8D2Q30366407-705A32BA-26F1-4518-B393-DEB5A875349FQ33248641-2986840F-BB1D-45C2-8011-FB767C9AFF7EQ33552832-3CE936DA-71B4-497A-A7D2-3F4FF611FBEDQ33618740-09A97456-6C74-4C3F-AE26-3B6A18946E35Q33649039-DB0B626A-45A0-4657-87EC-FD54E2FA9E66Q33787132-95E3E822-0EB0-4CC7-9F40-23B98DD63FF1Q33988586-FFA6BF3B-98FE-461E-8C18-A1728DB3AF4EQ34053726-4758977B-9FFF-4522-93FD-64B039404637Q34230585-EFA9B573-D884-4BA7-8FEF-8C1679081489Q34389709-4022ADA0-4C14-4744-9A1A-688C7F84B3B8Q34580906-979D1A8A-ED71-4551-A108-A6C86E43607DQ34771678-AA872AA2-C5BE-4B30-A60D-C5108C2FA540Q34958145-DB9D977A-2F84-461F-9C00-4E5FF130A782Q34988085-8078DFCA-70B2-4EB0-AC67-8134B1DFF0F5Q36237549-EDCD7F9F-C867-4DC2-A975-D2A019698F4CQ36281598-C73BACD6-C556-4974-9C95-4A591CD58858Q36291789-C6C6510D-9576-49DF-891F-746022AC89AAQ36389447-56AC815D-AC05-49B1-8FE3-AA7592E6751BQ36389497-B7F62601-DFA3-4770-A3C2-A0AF4D20B86EQ36415580-D0FF4268-7806-4D8B-8EA4-68638265518CQ36491748-03C070DC-5D19-46DB-8B91-504E90839957Q36506290-490269A6-80DE-486C-81CF-22E5B5230909Q36743649-932C92A8-9C3B-406C-8B48-B8DCE82CFAAAQ36814387-040ADBE2-FB4B-446F-BFDF-73419FD35C2CQ36916318-B9D647E3-ACA8-4299-AFDD-152F490E2F68Q37195543-D07516DC-521B-411C-9CDD-58B7F2016122Q37265609-E28395EC-D49E-4C2B-86C8-B58B61D09566Q37311716-1BCAF43F-62BB-420B-9E13-A966A9191ED7Q37349973-AC2B9787-3F60-4D8B-8174-A1E565645CA8Q37388018-A4F29753-2B07-4C54-8830-B69190B03BC1Q38271599-BA603958-F0DB-4B3D-868F-CD5AC1808AF8
P2860
Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Hepatitis B virus X antigen in ...... t of hepatocellular carcinoma.
@ast
Hepatitis B virus X antigen in ...... t of hepatocellular carcinoma.
@en
type
label
Hepatitis B virus X antigen in ...... t of hepatocellular carcinoma.
@ast
Hepatitis B virus X antigen in ...... t of hepatocellular carcinoma.
@en
prefLabel
Hepatitis B virus X antigen in ...... t of hepatocellular carcinoma.
@ast
Hepatitis B virus X antigen in ...... t of hepatocellular carcinoma.
@en
P2860
P1476
Hepatitis B virus X antigen in ...... t of hepatocellular carcinoma.
@en
P2093
M A Feitelson
P2860
P304
P407
P577
1997-04-01T00:00:00Z